Nocardia mediterranei

No·car·di·a med·i·ter·ra·'ne·i

a bacterial species that produces rifamycin.
Farlex Partner Medical Dictionary © Farlex 2012

No·car·di·a med·i·ter·ra·ne·i

(nō-kahr'dē-ă med'i-tĕr-ā'nē-ī)
A bacterial species that produces rifamycin.
Medical Dictionary for the Health Professions and Nursing © Farlex 2012
References in periodicals archive ?
Wang et al., "Chemomicin A, a new angucyclinone antibiotic produced by Nocardia mediterranei subsp.
Rifamycin B is powerful, less toxic, and easily biodegradable antibacterial ansamycin antibiotic [1] and is produced by strain of Nocardia mediterranei. It bear distinct critical antibacterial activities [2], including tuberculosis, leprosy, and AIDS-related mycobacterial infections [3].
Nocardia mediterranei MTCC14 was obtained from the Microbial Type Culture Collection and Gene Bank (MTCC), Chandigarh, India, and was used in this study for rifamycin B production.
Plackett-Burman design test was applied to describe the significant variables responsible for production of rifamycin B from Nocardia mediterranei MTCC 14.
The complementary nutrients and physical parameters really advance concentration of rifamycin B of Nocardia mediterranei MTCC 14.
Hence, the effect of different nitrogen sources on rifamycin B production by Nocardia mediterranei MTCC 14 was studied at optimized SSF environment.
Analysis of variance for the rifamycin B produced from Nocardia mediterranei MTCC 14 obtained from this design was given in Table 6.
Optimum levels of production parameters for production of rifamycin B from Nocardia mediterranei MTCC14 was 9.87 g/kgds, which is very close to the predicted value of 10.35 g/kgds.
Response surface methodology was well used to optimize the production parameters for production of rifamycin B from Nocardia mediterranei MTCC 14.